Literature DB >> 17239494

Electric pulses applied prior to intramuscular DNA vaccination greatly improve the vaccine immunogenicity.

Baowei Peng1, Yonggang Zhao, Lingyun Xu, Yuhong Xu.   

Abstract

Electroporation can improve intramuscular DNA vaccination efficacy but the exact antigen presentation mechanism remains unclear. We reported here that a similar immuno-potentiation effect was also observed by stimulating the skeletal muscles with electric pulses (EP) a few days prior to DNA inoculation (EP + n days + DNA). The application of EP by itself activated proinflammatory chemokine genes and stress genes. It also triggered an influx of inflammatory monocytes/macrophages (MPs). After DNA inoculation, the plasmids were seen taken up by these inflammatory MPs, which migrated to the draining LNs subsequently. The antibody responses results were fast and strong. Furthermore, MPs isolated from the draining LNs of EP + n days + DNA treated mice were capable of stimulating Ag specific CD4+ T cell proliferation in vitro. Based on these observations, we proposed that the local inflammation resulted from EP treatment played an important role in facilitating antigen presentation of the DNA vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17239494     DOI: 10.1016/j.vaccine.2006.11.042

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation.

Authors:  Ralph LeBlanc; Yessika Vasquez; Drew Hannaman; Nirbhay Kumar
Journal:  Vaccine       Date:  2007-11-20       Impact factor: 3.641

2.  Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer.

Authors:  C Trollet; Y Pereira; A Burgain; E Litzler; M Mezrahi; J Seguin; M Manich; M R Popoff; D Scherman; P Bigey
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

3.  Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation.

Authors:  Chae Young Kim; Eun Sung Kang; Seon Beom Kim; Han Eol Kim; Jae Hoon Choi; Dong Sop Lee; Se Jin Im; Se Hwan Yang; Young Chul Sung; Byong Moon Kim; Byung Gee Kim
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

4.  DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.

Authors:  Gunnveig Grodeland; Siri Mjaaland; Kenneth H Roux; Agnete Brunsvik Fredriksen; Bjarne Bogen
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

5.  Electroporation-mediated gene delivery.

Authors:  Jennifer L Young; David A Dean
Journal:  Adv Genet       Date:  2014-12-11       Impact factor: 1.944

6.  Innate Molecular and Cellular Signature in the Skin Preceding Long-Lasting T Cell Responses after Electroporated DNA Vaccination.

Authors:  Lucille Adam; Nicolas Tchitchek; Biliana Todorova; Pierre Rosenbaum; Candie Joly; Candice Poux; Catherine Chapon; Anna-Lena Spetz; Mart Ustav; Roger Le Grand; Frédéric Martinon
Journal:  J Immunol       Date:  2020-05-08       Impact factor: 5.422

7.  Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.

Authors:  Simon R Best; Shiwen Peng; Chi-Mou Juang; Chien-Fu Hung; Drew Hannaman; John R Saunders; T-C Wu; Sara I Pai
Journal:  Vaccine       Date:  2009-07-19       Impact factor: 3.641

Review 8.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

9.  Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination.

Authors:  Gunnveig Grodeland; Agnete Brunsvik Fredriksen; Geir Åge Løset; Elisabeth Vikse; Lars Fugger; Bjarne Bogen
Journal:  J Immunol       Date:  2016-09-26       Impact factor: 5.422

10.  Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.

Authors:  T H Kang; J-Y Chung; A Monie; S I Pai; C-F Hung; T-C Wu
Journal:  Gene Ther       Date:  2009-11-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.